Old Web
English
Sign In
Acemap
>
authorDetail
>
Beth A. Christian
Beth A. Christian
James Cancer Hospital
Refractory
Immunology
Medicine
Nivolumab
Brentuximab vedotin
3
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pembrolizumab in relapsed or refractory Richter syndrome.
2020
British Journal of Haematology
Philippe Armand
Niels Murawski
Daniel Molin
Jasmine Zain
Barbara Eichhorst
Zafer Gulbas
Eliza A Hawkes
John M. Pagel
Tycel J. Phillips
Vincent Ribrag
Jakub Svoboda
Anastasios Stathis
Arkendu Chatterjee
Robert Orlowski
Patricia Marinello
Beth A. Christian
Show All
Source
Cite
Save
Citations (8)
Brentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 Study
2019
Blood
Alison J. Moskowitz
Ranjana H. Advani
Nancy L. Bartlett
Julie M. Vose
Radhakrishnan Ramchandren
Tatyana Feldman
Ann S. LaCasce
Beth A. Christian
Stephen M. Ansell
Craig H. Moskowitz
Lisa Brown
David Taft
Sahar Ansari
Daniel E. Zak
Mariana Sacchi
Thomas Manley
Alex F. Herrera
Show All
Source
Cite
Save
Citations (14)
Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Classic Hodgkin Lymphoma: Part 3 (Concurrent Dosing) Results and Updated Progression-Free Survival Results from Parts 1 and 2 (Staggered Dosing)
2018
Blood
Ranjana H. Advani
Alison J. Moskowitz
Nancy L. Bartlett
Julie M. Vose
Radhakrishnan Ramchandren
Tatyana Feldman
Ann S. LaCasce
Beth A. Christian
Stephen Maxted Ansell
Craig H. Moskowitz
Keenan Fenton
Carol Anne Ogden
David Taft
Daniel E. Zak
Mariana Sacchi
Faith Galderisi
Alex F. Herrera
Show All
Source
Cite
Save
Citations (6)
1